Related Experiment Videos

[Administration of vitamin K to neonates and infants]

J Uitentuis1

  • 1Studiegroep Zuigelingenvoeding van de Nationale Kruisvereniging, 's-Gravenhage.

Insights

All healthy newborns should receive 1 mg of oral vitamin K1 at birth to prevent haemorrhagic disease of the newborn (HDN). Breastfed infants require daily vitamin K1 supplementation for the first three months.

Area of Science:

  • Pediatrics
  • Nutritional Science
  • Neonatology

Context:

  • Haemorrhagic disease of the newborn (HDN) is a preventable condition.
  • Current prophylactic guidelines for vitamin K1 are established by Dutch health organizations.
  • Vitamin K1 deficiency can lead to serious bleeding complications in infants.

Purpose:

  • To outline the recommended vitamin K1 prophylaxis for newborns in the Netherlands.
  • To summarize the current understanding of vitamin K deficiency and HDN.
  • To identify areas requiring further research in vitamin K1 supplementation.

Summary:

  • A single oral dose of 1 mg vitamin K1 at birth is recommended for all healthy infants to prevent HDN.
  • Parenteral vitamin K1 is advised for high-risk newborns.
  • Daily oral vitamin K1 (25-50 mcg) is recommended for breastfed infants for the first three months.

Impact:

  • Ensures consistent vitamin K1 prophylaxis for newborns, reducing HDN incidence.
  • Provides clear guidelines for pediatricians and healthcare providers.
  • Highlights the importance of vitamin K1 for infant health and development.

Related Concept Videos